The human anti-mouse antibody (HAMA) reaction limits the therapeutic utility of mouse monoclonal antibodies. Humanization of mouse monoclonal antibodies by genetic engineering can improve the in ...

Ablexis and AlivaMab Discovery Services together launch antibody drug discovery and development projects on the fastest and most de-risked path to success. Ablexis invented and licenses the ...

The impacts of next-generation sequencing (NGS) can be seen throughout multiple phases of therapeutic antibody development, from discovery and engineering to manufacturing. Sequencing is a ...